IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

AGOSTONI, ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.794
NA - Nord America 2.729
AS - Asia 2.186
SA - Sud America 294
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 10.032
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.649
GB - Regno Unito 2.065
DE - Germania 1.066
CN - Cina 733
SG - Singapore 437
SE - Svezia 435
IT - Italia 291
RU - Federazione Russa 242
TR - Turchia 219
BR - Brasile 217
VN - Vietnam 203
HK - Hong Kong 193
NL - Olanda 193
KR - Corea 188
UA - Ucraina 124
IE - Irlanda 117
IN - India 94
EU - Europa 93
FR - Francia 87
FI - Finlandia 83
CA - Canada 70
CO - Colombia 56
GR - Grecia 28
ID - Indonesia 23
PL - Polonia 19
JP - Giappone 15
BE - Belgio 13
IR - Iran 12
BD - Bangladesh 11
IQ - Iraq 9
AT - Austria 8
AR - Argentina 7
ZA - Sudafrica 7
ES - Italia 6
YE - Yemen 6
IL - Israele 5
MA - Marocco 5
MX - Messico 5
PK - Pakistan 5
UZ - Uzbekistan 5
KE - Kenya 4
NP - Nepal 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EC - Ecuador 3
LT - Lituania 3
PY - Paraguay 3
RO - Romania 3
CH - Svizzera 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
LK - Sri Lanka 2
OM - Oman 2
PE - Perù 2
QA - Qatar 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
GE - Georgia 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
PT - Portogallo 1
RS - Serbia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 10.122
Salva come PNG Salva come JPEG
Città #
Southend 1.891
Chandler 326
Singapore 312
Seattle 246
Princeton 196
Hong Kong 183
Beijing 155
Wilmington 148
Ashburn 129
Dublin 117
Santa Clara 114
Redmond 110
Dong Ket 108
Somerville 105
Council Bluffs 93
Milan 84
Fairfield 78
Jacksonville 77
Sakarya 74
Nanjing 70
Odernheim 61
Des Moines 60
Mountain View 60
Ann Arbor 59
Woodbridge 59
Andover 56
Bogotá 56
Toronto 56
Houston 46
Bengaluru 42
Boardman 41
Dearborn 37
Serra 37
Jinan 34
Geisenheim 33
Guangzhou 33
Seoul 29
Hebei 27
Athens 26
Berlin 26
Saint Petersburg 26
Shanghai 25
Shenyang 25
Phoenix 24
Cangzhou 22
Grafing 22
Fuzhou 21
Seongnam 21
Nanchang 20
Redwood City 20
Cambridge 19
São Paulo 19
Taizhou 18
Bitonto 17
Tianjin 15
Hanover 14
Turin 14
Warsaw 14
Zhengzhou 14
Columbus 13
Falls Church 13
Fremont 13
Los Angeles 13
New York 13
Pune 13
Changsha 12
Mainz 12
Ningbo 12
San Diego 12
Mumbai 11
The Dalles 11
Bologna 10
Brussels 10
Chongqing 10
Eitensheim 10
Jiaxing 10
Tokyo 10
Hangzhou 9
Munich 9
Wuhan 9
Haikou 8
Jakarta 8
Kwai Chung 8
Quanzhou 8
Hefei 7
Helsinki 7
Lanzhou 7
Norwalk 7
Nuremberg 7
Rio de Janeiro 7
Karaj 6
Kiez 6
London 6
San Jose 6
Verona 6
Ahnsen 5
Amsterdam 5
Dallas 5
Pisa 5
Sanaa 5
Totale 6.228
Salva come PNG Salva come JPEG
Nome #
Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin 441
Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner 256
Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema 217
Consumption of C4b-binding protein (C4BP) during in vivo activation of the classical complement pathway 197
Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies 187
Hereditary and acquired angioedema : problems and progress : proceedings of the third C1 esterase inhibitor deficiency workshop and beyond 182
Haemostasis contact system and fibrinolysis in hereditary angioedema (C1-inhibitor deficiency) 167
Pathogenetic and clinical aspects of C1-inhibitor deficiency 166
Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator 166
Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C 165
Fibrinolytic response in normal subjects to venous occlusion and DDAVP infusion 165
Frequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedema 163
Non neutralizing antibodies to tissue type plasminogen activator in serum of acute myocardial infarction patients treated with the recombinant protein 163
Angioedema associated with angiotensin-converting enzyme inhibitor use : outcome after switching to a different treatment 160
C1 inhibitor function and anti-C1 inhibitor autoantibodies in patients with HIV type 1 infection 160
Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies 159
Problemi di emocoagulazione in corso di circolazione extracorporea a lungo termine 157
Cardiopulmonary by-pass in a patient with acquired C1 inhibitor deficiency 155
Tissue-type plasminogen activator and von Willebrand factor plasma levels as markers of endothelial involvement in patients with Raynaud's phenomenon 155
Physiopathology and management of coagulation during long-term extracorporeal respiratory assistance 155
DDAVP infusion does not affect plasma levels of endothelin-1 in four normal subjects 154
Idiopathic nonhistaminergic angioedema 153
Angioedema due to angiotensin-converting enzyme inhibitors 152
Treatment of acute attacks of hereditary angioedema with C1-inhibitor concentrate 152
Evaluation of tests for heparin control during long-term extracorporeal circulation 151
Hepatic function and fibrinolysis in patients with hereditary angioedemaundergoing long-term treatment with tranexamic acid 151
Disseminated intravascular coagulation (DIC) during long-term bypass : incidence and clinical relevance 150
Activation of the contact system and fibrinolysis in autoimmune acquired angioedema : a rationale for prophylactic use of tranexamic acid 150
Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema 150
Bradykinin and the pathophysiology of angioedema 146
Bradykinin in the ascitic fluid of patients with liver cirrhosis 146
L-arginine therapy in Raynaud's phenomenon? 143
Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease 143
Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angioedema 142
Autoimmune C1 inhibitor deficiency : report of eight patients 142
Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosis 141
Activation of the contact system in cerebrospinal fluid of patients with Alzheimer disease 141
Hereditary angioedema: an appraisal of 104 cases 141
Cleavage of high molecular weight kininogen in ascites and plasma of patients with cirrhosis 139
Plasma levels of tissue-type plasminogen activator and von Willebrand factor in patients with Raynaud's phenomenon 139
Statistical evaluation of commonly used tests for heparin monitoring 138
Side effects of long-term prophylaxis with attenuated-androgens in hereditary angioedema : comparison between treated and non-treated patients 132
Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome 131
C1-inhibitor concentrate for treatment of hereditary angioedema 131
Cardioprotective effect of C1-inhibitor 129
Effect of PGI2 infusion during long term extracorporeal circulation with membrane lung in sheep 129
Infusion of C1-inhibitor plasma concentrate prevents hyperamylasemia induced by endoscopic sphincterotomy 127
Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives 125
Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors 121
C1 INH concentrate in the therapy of hereditary angioedema 121
Hereditary angioneurotic oedema 121
Drug-induced angioedema without urticaria 120
Leucotriene B4 and peptido-leucotriene levels during radiographic contrast media infusion 119
Intermittent therapy with danazol in hereditary angioedema 118
Plasma bradykinin levels in human chronic congestive heart failure 114
Thrombolytic treatment and complement activation 112
Clinical problems in the C1-inhibitor deficient patient 110
Plasma bradykinin in angio-oedema 105
Acquired C1 inhibitor deficiency with angioedema symptoms in a patient infected with Echinococcus granulosus 105
Local bradykinin generation in hereditary angioedema. 104
Long-term treatment of hereditary angioedema with attenuated androgens : a survey of a 13-year experience 104
Cardiopulmonary bypass increases plasma bradykinin concentrations 102
Generation of plasmin during acute attacks of hereditary angioedema 99
Influence of contact system deficiencies during cardiopulmonary bypass 97
In vitro interaction of C1-inhibitor with thrombin 97
Hereditary angioedema 95
Effect of treatment with 17alpha-alkylated androgens on C4 conversion products in hereditary angioedemastudied by crossed immunoelectrophoresis 94
Immunoreactive precipitation of C1 inhibitor protein from plasma of normalsubjects and of patients with hereditary angioedema after isoelectric focusing 93
Increase of bradykinin in plasma of patients undergoing cardiopulmonary bypass : the importance of lung exclusion 85
In vivo study of the complement system during infusion ofradiographic contrast media 84
Hereditary and acquired C1-inhibitor deficiency : biological and clinical characteristics in 235 patients 82
The systemic capillary leak syndrome : appearance of interleukin-2-receptor-positivecells during attacks 82
Complement deficiency and antibodyprofile in survivors of meningococcal meningitis due to common serogroups in Italy 80
Replacement therapy in hereditary and acquired angioedema 79
Restriction fragment length polymorphism of the C1 inhibitor gene in hereditaryangioneurotic edema 78
Treatment of hereditary angioedema 76
Nonsensemutations affect C1 inhibitor messenger RNA levels in patients with type Ihereditary angioneurotic edema 69
Totale 10.570
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.494
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.071 71 30 69 11 84 59 45 96 87 41 234 244
2021/2022963 106 30 22 82 57 58 103 112 92 74 108 119
2022/20231.027 161 113 82 121 110 216 13 60 108 12 29 2
2023/2024441 24 44 19 14 89 48 14 27 5 19 68 70
2024/20251.576 51 125 26 186 180 57 78 168 89 167 107 342
2025/2026102 102 0 0 0 0 0 0 0 0 0 0 0
Totale 10.570